Mary Jenkins | executive |
Douglas Ingram | executive |
Dallan Murray | executive |
Louise Rodino-Klapac | executive |
Ian Estepan | executive |
Good afternoon and welcome to the Sarepta Therapeutics First Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, today's program is being recorded.
At this time, I'll turn the call over to Mary Jenkins, Associate Director, Investor Relations and Corporate Communications. Please go ahead.
Thank you, Victor, and thank you all for joining today's call.